Interpretation of the Seattle Angina Questionnaire as an outcome measure in clinical trials and clinical care: a review
M Thomas, PG Jones, SV Arnold, JA Spertus - JAMA cardiology, 2021 - jamanetwork.com
Importance Patient-reported outcomes are increasingly used as end points in clinical trials,
assessments in clinical care, and tools for population health, with an increasing role in …
assessments in clinical care, and tools for population health, with an increasing role in …
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American …
SD Fihn, JM Gardin, J Abrams, K Berra… - Journal of the American …, 2012 - jacc.org
The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted as the document was compiled through …
extensive evidence review was conducted as the document was compiled through …
Role of ranolazine in angina, heart failure, arrhythmias, and diabetes
S Sossalla, LS Maier - Pharmacology & therapeutics, 2012 - Elsevier
Ranolazine which is currently approved as an antianginal agent reduces the Na-dependent
Ca overload via inhibition of the late sodium current (late INa) and thus improves diastolic …
Ca overload via inhibition of the late sodium current (late INa) and thus improves diastolic …
Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes …
Objectives: This study sought to examine the efficacy of ranolazine versus placebo on
weekly angina frequency and sublingual nitroglycerin use in subjects with type 2 diabetes …
weekly angina frequency and sublingual nitroglycerin use in subjects with type 2 diabetes …
[HTML][HTML] 2023 Guidelines of the Taiwan Society of Cardiology on the diagnosis and management of chronic coronary syndrome
KC Ueng, CE Chiang, TH Chao, YW Wu… - Acta Cardiologica …, 2023 - ncbi.nlm.nih.gov
Coronary artery disease (CAD) covers a wide spectrum from persons who are asymptomatic
to those presenting with acute coronary syndromes (ACS) and sudden cardiac death …
to those presenting with acute coronary syndromes (ACS) and sudden cardiac death …
Comparison of the Seattle Angina Questionnaire with daily angina diary in the TERISA clinical trial
SV Arnold, M Kosiborod, Y Li, PG Jones… - … Quality and Outcomes, 2014 - Am Heart Assoc
Background—As new techniques emerge to quantify patients' health status, new
opportunities are created to validate patient-reported outcome questionnaires. The Seattle …
opportunities are created to validate patient-reported outcome questionnaires. The Seattle …
Pharmacological and emerging therapies in the treatment of chronic angina
SE Husted, EM Ohman - The Lancet, 2015 - thelancet.com
Chronic angina is a common manifestation of ischaemic heart disease. Medical treatments
are the mainstay approach to reduce the occurrence of angina and improve patients' quality …
are the mainstay approach to reduce the occurrence of angina and improve patients' quality …
Effects of ranolazine on angina and quality of life after percutaneous coronary intervention with incomplete revascularization: results from the ranolazine for incomplete …
KP Alexander, G Weisz, K Prather, S James, DB Mark… - Circulation, 2016 - Am Heart Assoc
Background—Angina often persists or returns in populations following percutaneous
coronary intervention (PCI). We hypothesized that ranolazine would be effective in reducing …
coronary intervention (PCI). We hypothesized that ranolazine would be effective in reducing …
Assessing quality-of-life outcomes in cardiovascular clinical research
DB Mark - Nature Reviews Cardiology, 2016 - nature.com
The field of quality-of-life (QOL) measurement grew out of attempts in the 1960s and 1970s
to connect the ever-increasing levels of public expenditure on technology-based health care …
to connect the ever-increasing levels of public expenditure on technology-based health care …
Cardiac arrhythmias related to sodium channel dysfunction
E Savio-Galimberti, M Argenziano… - Voltage-gated sodium …, 2018 - Springer
The voltage-gated cardiac sodium channel (Na v 1.5) is a mega-complex comprised of a
pore-forming α subunit and 4 ancillary β-subunits together with numerous protein partners …
pore-forming α subunit and 4 ancillary β-subunits together with numerous protein partners …